4 results
Primary:* To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0…
To provide preliminary technical feasibility, safety and efficacy data foreCLIPs Family of products.
Primary objective:* To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active CD who achieved clinical response at Week 6 following administration of vedolizumab IV…
To gather electrocardiogram, pulse oximeter and heart rate analog front-end, accelerometer and temperature data of patients undergoing electrical carioversion (ECV) for the treatment of AF, and to use the data for the training and validation of Afi…